Search

Your search keyword '"Khan, A."' showing total 4,789 results

Search Constraints

Start Over You searched for: Author "Khan, A." Remove constraint Author: "Khan, A." Journal blood Remove constraint Journal: blood
4,789 results on '"Khan, A."'

Search Results

1. A genetic association study of circulating coagulation factor VIII and von Willebrand factor levels

2. An LGR6 frameshift variant abrogates receptor expression on select leukocyte subsets and is associated with viral infections

3. Atypical hemolytic uremic syndrome in the era of terminal complement inhibition: an observational cohort study

7. S100A8/A9 drives the formation of procoagulant platelets through GPIbα

8. Hematopoietic stem cell transplantation for adolescents and adults with inborn errors of immunity: an EBMT IEWP study

9. HMGB1-mediated restriction of EPO signaling contributes to anemia of inflammation

10. Structural racism is a mediator of disparities in acute myeloid leukemia outcomes

11. Single-route CNS prophylaxis for aggressive non-Hodgkin lymphomas: real-world outcomes from 21 US academic institutions

12. Fecal microbiota diversity disruption and clinical outcomes after auto-HCT: a multicenter observational study

13. Multiomics analysis of IgM monoclonal gammopathies reveals epigenetic influence on oncogenesis via DNA methylation

14. Burkitt lymphoma in the modern era: real-world outcomes and prognostication across 30 US cancer centers

15. Oral 5-azacytidine and romidepsin exhibit marked activity in patients with PTCL: a multicenter phase 1 study

17. Platelets Sequester Extracellular DNA, Capturing Tumour-Derived and Free Fetal DNA

21. Murine allogeneic CAR T cells integrated before or early after posttransplant cyclophosphamide exert antitumor effects

22. S100A8/A9 drives the formation of procoagulant platelets through GPIbα

24. Promising efficacy and acceptable safety of venetoclax plus bortezomib and dexamethasone in relapsed/refractory MM

25. Pomalidomide, bortezomib, and dexamethasone for patients with relapsed lenalidomide-refractory multiple myeloma

27. Pembrolizumab in patients with CLL and Richter transformation or with relapsed CLL

29. Multivariable Analyses of Prognostic Factors for Progression-Free Survival (PFS) and Complete Response (CR) with Lenalidomide, Bortezomib, and Dexamethasone (RVd) Alone Versus Rvd Plus Autologous Stem Cell Transplantation (ASCT) in Patients (Pts) with Newly Diagnosed Multiple Myeloma (NDMM) in the Determination Phase 3 Trial

30. Risk factors for severe infection and mortality in COVID-19 and monoclonal gammopathy of undetermined significance

31. Hematopoietic stem cell transplantation for adolescents and adults with inborn errors of immunity: an EBMT IEWP study

37. The Promise of Next-Generation Sequencing in Improving the Diagnosis of Rare Genetic Disorders in Developing Countries

39. Efficacy and Safety of IDH Inhibitors in AML: A Systematic Review of Clinical Trials

40. Molecular MRD Assessment Is Strongly Prognostic in Patients with NPM1 Mutated AML Receiving Venetoclax Based Non-Intensive Therapy

41. Brentuximab Vedotin Combined with Chemotherapy in Newly Diagnosed, Early-Stage, Unfavorable-Risk Hodgkin Lymphoma: Extended Follow-up with Evaluation of Baseline Metabolic Tumor Volume and PET2

42. Integrative Genomics Identifies a High-Risk Metabolic and TME Depleted Signature That Predicts Early Clinical Failure in DLBCL

44. Impact of Daratumumab-Containing Regimens in Outcomes of Subsequent Treatments of Relapsed Multiple Myeloma in Real-World Practice from the Canadian Myeloma Research Group Database

46. Assessing the Burden of Adverse Events in a Head-to-Head Trial of Acalabrutinib Versus Ibrutinib in Previously Treated Chronic Lymphocytic Leukemia (CLL)

47. Integrating Mosaic Chromosomal Alterations and Single-Nucleotide Variants to Predict Evolution of Clonal Hematopoiesis

50. Deep Multi-Omics Profiling in Cytogenetically Poor-Risk AML

Catalog

Books, media, physical & digital resources